Maxim upbeat on Atossa Therapeutics after recent updates : v

Analysts at Maxim Group have reiterated a 'buy' rating on Atossa Therapeutics Inc (NASDAQ:ATOS) shares after the biotech recently announced an enrollment...

Related Keywords

Kyle Guse , Atossa Therapeutics Inc , Analysts At Maxim Group , Maxim Group , Greg Weaver ,